Tue, August 3, 2010
Mon, August 2, 2010
Fri, July 30, 2010
Thu, July 29, 2010
Wed, July 28, 2010
Tue, July 27, 2010
Mon, July 26, 2010
Fri, July 23, 2010
Thu, July 22, 2010
Wed, July 21, 2010
Tue, July 20, 2010
[ Tue, Jul 20th 2010 ] - Market Wire
00 AM EDT
Mon, July 19, 2010
Sun, July 18, 2010
Sat, July 17, 2010
Fri, July 16, 2010
Thu, July 15, 2010
Wed, July 14, 2010

SuperGen to Announce 2010 Second Quarter Financial Results on August 2, 2010


//health-fitness.news-articles.net/content/2010/ .. -quarter-financial-results-on-august-2-2010.html
Published in Health and Fitness on Monday, July 26th 2010 at 6:30 GMT by Market Wire   Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it will release its 2010 second quarter financial results on Monday, August 2, 2010. SuperGen's management team will provide details of the Company's financial results and any revised outlook for the future.

A press release will be issued following the close of the market on August 2nd. The Company will host a webcast conference call to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. A live webcast of the call will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing (800) 642-1687 (domestic) and (706) 645-9291 (international); replay passcode number is 88583885. The webcast replay and conference call replay will be available for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].


Publication Contributing Sources